Novo Nordisk

Key Points Novo Nordisk is launching a new, more effective version of Wegovy. Even with this new approval, the company likely won't catch up to its biggest co...

(RTTNews) - Novo Nordisk [NVO] announced on Wednesday, that it has received a significant boost after the National Institute for Health and Care Excellence reco...

Shares of Novo Nordisk (NVO) are in focus at midday after the Food and Drug Administration approved Eli Lilly’s (LLY) GLP-1 pill. Eli Lilly announced on Wednesd...

In March 2026, Hims & Hers Health announced a collaboration with Novo Nordisk to offer eligible customers a broad range of FDA-approved GLP-1 medications, inclu...

Fourth quarter results include a net gain of $237.6 million tied to the zaltenibart transaction with Novo Nordisk. The fourth quarter also includes a $136.0 mil...

Novo Nordisk Launches Wegovy Subscription Plans to Lower Costs and Boost Patient Retention Novo Nordisk is introducing multi-month subscription plans for its W...

Earlier in March, the U.S. Food and Drug Administration (FDA) approved a higher-dose version of Wegovy, marking an expansion of its treatment portfolio for adul...

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

07:47 EDT Novo Nordisk (NVO) launches multi-month subscription program for Wegovy Published first on TheFly – the ultimate source for real-time, market-moving...

Key Points Novo Nordisk launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients pay lower, "pr...